Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Integrated Sciences Inc
(NQ:
NVOS
)
0.3700
-0.0100 (-2.63%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novo Integrated Sciences Inc
< Previous
1
2
3
Next >
Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results
July 19, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program
July 18, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program
June 13, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million
June 06, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products
June 05, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note
June 03, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
May 31, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program
May 30, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
April 15, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
April 11, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
March 26, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
February 21, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
February 20, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Appoints New President
February 16, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
January 22, 2024
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
December 19, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
December 14, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
December 05, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval
December 04, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 24, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Reverse Stock Split
November 06, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days
November 06, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond
November 03, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Provides Update on Certain Current Events
October 06, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Board of Directors Approves $5 Million Stock Repurchase Program
October 24, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Signs Master Collateral Transfer Agreement
September 28, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
September 21, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health
September 13, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Provides Update on Potential Share Repurchase Program
September 08, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 Coupon
August 31, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.